Replies to post #758390 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

With all the things that are lined up to kick off on approval , NWBO will get plenty of attention through PRs and news media. It will still be talked about at ASCO by others.

The above is only true provided that NWBO wholeheartedly implements a radically different public and investor relations strategy than they have used since they surrendered to Dr. Buzdar against the advice of shareholders like myself and broke their commitment to move forward undeterred.

My concern is that they might not change just because they get MHRA approval because the strategy of silence has become part of NWBO’s corporate DNA and is impervious to evidence that is does not work. They have doubled down on that mistake year over year even though the outcome for shareholders has been far, far worse than what those shareholders who remonstrated with them could have predicted back then.

So it all comes down to this:

Does NWBO even recognize that they need to treat MHRA approval as a game changing moment especially when it comes to having clear communication with the media and investors?

Does NWBO even have the capacity to si dramatically change themselves or will they fall back on their old ways of hiding in their bunker in the face of any criticism?

Has NWBO does any meaningful engagement with the media or big investors behind the scenes that will immediately trigger upon MHRA approval or are they (as their history seems to show) handling every problem sequentially and thus moving from a cold start and not pedal to the metal as was claimed before we knew better?